Clinical case definitions and malaria vaccine efficacy

Journal of Infectious Diseases

Volumn 193, Issue 3, 2006, Pages 467-473

  Rogers, William O ^a,c,d   Atuguba, Frank ^b   Oduro, Abraham R ^b   Hodgson, Abraham ^b   Koram, Kwadwo A ^a  

^a University of Ghana   (Ghana)

^b NAVRONGO HEALTH RESEARCH CENTRE   (Ghana)

^c US Naval Medical Research Unit No 3 Egypt   (Egypt)

^d NAMRU2 ^*  (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; GHANA; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALARIA; MALE; PARASITEMIA; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; CHILD, PRESCHOOL; FEMALE; FEVER; GHANA; HUMANS; INCIDENCE; INFANT; LOGISTIC MODELS; MALARIA; MALARIA VACCINES; MALE; PARASITEMIA; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 31044446842     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/499314     Document Type: Article

References (15)

1. Blackwelder WC, Storsaeter J, Olin P, Hallander HO. Acellular pertussis vaccines: efficacy and evaluation of clinical case definitions. Am J Dis Child 1991; 145:1285-9.
2. Lachenbruch PA. Sensitivity, specificity, and vaccine efficacy. Control Clin Trials 1998; 19:569-74.
3. Stoute JA, Slaoui M, Heppner DG, et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N Engl J Med 1997; 336:86-91.
4. Ohrt C, Purnomo, Sutamihardja MA, Tang D, Kain KC. Impact of microscopy error on estimates of protective efficacy in malaria-prevention trials. J Infect Dis 2002; 186:540-6.
5. Smith T, Schellenberg JA, Hayes R. Attributable fraction estimates and case definitions for malaria in endemic areas. Stat Med 1994; 13:2345-58.
6. Appawu M, Owusu-Agyei S, Dadzie S, et al. Malaria transmission dynamics at a site in northern Ghana proposed for testing malaria vaccines. Trop Med Int Health 2004; 9:164-70.
7. Baird JK, Owusu AS, Utz GC, et al. Seasonal malaria attack rates in infants and young children in northern Ghana. Am J Trop Med Hyg 2002; 66:280-6.
8. Koram KA, Owusu-Agyei S, Fryauff DJ, et al. Seasonal profiles of malaria infection, anaemia, and bednet use among age groups and communities in northern Ghana. Trop Med Int Health 2003; 8:793-802.
9. Koram KA, Owusu-Agyei S, Utz G, et al. Severe anemia in young children after high and low malaria transmission seasons in the Kassena-Nankana District of northern Ghana. Am J Trop Med Hyg 2000; 62:670-4.
10. Owusu-Agyei S, Fryauff DJ, Chandramohan D, et al. Characteristics of severe anemia and its association with malaria in young children of the Kassena-Nankana District of northern Ghana. Am J Trop Med Hyg 2002; 67:371-7.
11. Owusu-Agyei S, Koram KA, Baird JK, et al. Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of northern Ghana. Am J Trop Med Hyg 2001; 65:197-203.
12. McKenzie FE, Sirichaisinthop J, Miller RS, Gasser RA Jr, Wongsrichanalai C. Dependence of malaria detection and species diagnosis by microscopy on parasite density. Am J Trop Med Hyg 2003; 69:372-6.
13. Mwangi TW, Ross A, Snow RW, Marsh K. Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J Infect Dis 2005; 191:1932-9.
14. Schofield L, Hewitt MC, Evans K, Siomos MA, Seeberger PH. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 2002; 418:785-9.
15. Alonso PL, Sacarlal J, Aponte JJ, et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 2004;364:1411-20.